位置:首页 > 蛋白库 > COE1_MOUSE
COE1_MOUSE
ID   COE1_MOUSE              Reviewed;         591 AA.
AC   Q07802;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   03-AUG-2022, entry version 172.
DE   RecName: Full=Transcription factor COE1;
DE            Short=O/E-1;
DE            Short=OE-1;
DE   AltName: Full=Early B-cell factor;
GN   Name=Ebf1; Synonyms=Coe1, Ebf;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 87-99; 122-129; 342-358
RP   AND 382-390.
RC   TISSUE=Lymphoid tissue;
RX   PubMed=8491377; DOI=10.1101/gad.7.5.760;
RA   Hagman J., Belanger C., Travis A., Turck W., Grosschedl R.;
RT   "Cloning and functional characterization of early B-cell factor, a
RT   regulator of lymphocyte-specific gene expression.";
RL   Genes Dev. 7:760-773(1993).
RN   [2]
RP   CHARACTERIZATION.
RX   PubMed=8497258; DOI=10.1128/mcb.13.6.3392-3400.1993;
RA   Travis A., Hagman J., Hwang L., Grosschedl R.;
RT   "Purification of early-B-cell factor and characterization of its DNA-
RT   binding specificity.";
RL   Mol. Cell. Biol. 13:3392-3400(1993).
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=1915300; DOI=10.1002/j.1460-2075.1991.tb04905.x;
RA   Hagman J., Travis A., Grosschedl R.;
RT   "A novel lineage-specific nuclear factor regulates mb-1 gene transcription
RT   at the early stages of B cell differentiation.";
RL   EMBO J. 10:3409-3417(1991).
RN   [4]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=7542362; DOI=10.1038/376263a0;
RA   Lin H., Grosschedl R.;
RT   "Failure of B-cell differentiation in mice lacking the transcription factor
RT   EBF.";
RL   Nature 376:263-267(1995).
RN   [5]
RP   SUBUNIT, AND ALTERNATIVE SPLICING.
RC   STRAIN=CD-1; TISSUE=Embryo;
RX   PubMed=9151732; DOI=10.1523/jneurosci.17-11-04149.1997;
RA   Wang S.S., Tsai R.Y.L., Reed R.R.;
RT   "The characterization of the Olf-1/EBF-like HLH transcription factor
RT   family: implications in olfactory gene regulation and neuronal
RT   development.";
RL   J. Neurosci. 17:4149-4158(1997).
RN   [6]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 24-241 IN COMPLEX WITH TARGET DNA
RP   AND ZINC, FUNCTION, SUBUNIT, AND MUTAGENESIS OF ARG-63; ASN-66; ARG-163;
RP   GLY-203 AND HIS-235.
RX   PubMed=20876732; DOI=10.1101/gad.1976610;
RA   Treiber N., Treiber T., Zocher G., Grosschedl R.;
RT   "Structure of an Ebf1:DNA complex reveals unusual DNA recognition and
RT   structural homology with Rel proteins.";
RL   Genes Dev. 24:2270-2275(2010).
RN   [7]
RP   FUNCTION.
RX   PubMed=20451411; DOI=10.1016/j.immuni.2010.04.013;
RA   Treiber T., Mandel E.M., Pott S., Gyoery I., Firner S., Liu E.T.,
RA   Grosschedl R.;
RT   "Early B cell factor 1 regulates B cell gene networks by activation,
RT   repression, and transcription- independent poising of chromatin.";
RL   Immunity 32:714-725(2010).
RN   [8]
RP   FUNCTION.
RX   PubMed=23812095; DOI=10.1038/ni.2641;
RA   Nechanitzky R., Akbas D., Scherer S., Gyoery I., Hoyler T., Ramamoorthy S.,
RA   Diefenbach A., Grosschedl R.;
RT   "Transcription factor EBF1 is essential for the maintenance of B cell
RT   identity and prevention of alternative fates in committed cells.";
RL   Nat. Immunol. 14:867-875(2013).
RN   [9]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=32130892; DOI=10.1016/j.celrep.2020.02.023;
RA   Angueira A.R., Shapira S.N., Ishibashi J., Sampat S., Sostre-Colon J.,
RA   Emmett M.J., Titchenell P.M., Lazar M.A., Lim H.W., Seale P.;
RT   "Early B Cell Factor Activity Controls Developmental and Adaptive
RT   Thermogenic Gene Programming in Adipocytes.";
RL   Cell Rep. 30:2869-2878.e4(2020).
CC   -!- FUNCTION: Key pioneer transcription factor of B-cell specification and
CC       commitment (PubMed:1915300, PubMed:7542362, PubMed:23812095).
CC       Recognizes variations of the palindromic sequence 5'-ATTCCCNNGGGAATT-3'
CC       (PubMed:20876732). Operates in a transcription factor network to
CC       activate B-cell-specific genes and repress genes associated with
CC       alternative cell fates (PubMed:23812095, PubMed:20451411). For
CC       instance, positively regulates many B-cell specific genes including BCR
CC       or CD40 while repressing genes that direct cells into alternative
CC       lineages, including GATA3 and TCF7 for the T-cell lineage
CC       (PubMed:23812095, PubMed:20451411). In addition to its role during
CC       lymphopoiesis, controls the thermogenic gene program in adipocytes
CC       during development and in response to environmental cold
CC       (PubMed:32130892). {ECO:0000269|PubMed:1915300,
CC       ECO:0000269|PubMed:20451411, ECO:0000269|PubMed:20876732,
CC       ECO:0000269|PubMed:23812095, ECO:0000269|PubMed:32130892,
CC       ECO:0000269|PubMed:7542362}.
CC   -!- SUBUNIT: Homodimer (PubMed:9151732, PubMed:20876732). Interacts with
CC       ZNF423 and ZNF521, leading to prevent EBF1 to bind DNA and activate
CC       target genes (By similarity). Interacts with CCR4-NOT component CNOT3
CC       (By similarity). {ECO:0000250|UniProtKB:Q9UH73,
CC       ECO:0000269|PubMed:20876732, ECO:0000269|PubMed:9151732}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:1915300}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long; Synonyms=8;
CC         IsoId=Q07802-1; Sequence=Displayed;
CC       Name=Short; Synonyms=O;
CC         IsoId=Q07802-2; Sequence=VSP_001112;
CC   -!- TISSUE SPECIFICITY: Expressed at high levels in early B-cells, spleen,
CC       lymph node and adipose tissue, and at low levels in heart, brain,
CC       skeletal muscle and kidney. In adult expressed in olfactory epithelium,
CC       in spleen, and at a lesser extent in Purkinje cells of the cerebellum,
CC       heart, kidney, lung, thymus and testis. In embryo expressed in dorsal
CC       thalamus and epithalamus, at a lower level in mesencephalon and in the
CC       caudal rhombencephalon, in the postmitotic cells of developing retina,
CC       highly in developing spinal cord, dorsal root ganglia, trigeminal
CC       ganglia and in glossopharyngeal nerve ganglia, in developing inner ear.
CC   -!- DEVELOPMENTAL STAGE: First detected at 9.5 dpc.
CC   -!- DISRUPTION PHENOTYPE: Targeted disruption in mice results in animals
CC       with a severe defect in early B-cell development. EBF1 heterozygous
CC       mice exhibit an approximately 2-fold decrease in the number of cells in
CC       the pro-B lymphocyte compartment, indicating that normal B-cell
CC       development depends on the presence of two wild-type EBF1 alleles
CC       (PubMed:7542362). Adipocyte-specific deletion mutant reveals a modest
CC       reduction of UCP1 expression, a mitochondrial protein responsible for
CC       thermogenic respiration. Double mutants EBF1/EBF2 show a more severe
CC       reduction of UCP1 expression (PubMed:32130892).
CC       {ECO:0000269|PubMed:32130892, ECO:0000269|PubMed:7542362}.
CC   -!- SIMILARITY: Belongs to the COE family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L12147; AAA37533.1; -; mRNA.
DR   CCDS; CCDS24566.1; -. [Q07802-1]
DR   PIR; A40684; A40684.
DR   RefSeq; NP_031923.1; NM_007897.3. [Q07802-1]
DR   RefSeq; XP_006532219.1; XM_006532156.3.
DR   PDB; 3MLN; X-ray; 2.40 A; A/B/E=24-241.
DR   PDB; 3MLO; X-ray; 3.01 A; A/B=24-241.
DR   PDB; 3MLP; X-ray; 2.80 A; A/B/E/F=24-421.
DR   PDBsum; 3MLN; -.
DR   PDBsum; 3MLO; -.
DR   PDBsum; 3MLP; -.
DR   AlphaFoldDB; Q07802; -.
DR   SMR; Q07802; -.
DR   BioGRID; 199358; 1.
DR   STRING; 10090.ENSMUSP00000080020; -.
DR   iPTMnet; Q07802; -.
DR   PhosphoSitePlus; Q07802; -.
DR   MaxQB; Q07802; -.
DR   PaxDb; Q07802; -.
DR   PRIDE; Q07802; -.
DR   ProteomicsDB; 283416; -. [Q07802-1]
DR   ProteomicsDB; 283417; -. [Q07802-2]
DR   Antibodypedia; 28482; 188 antibodies from 30 providers.
DR   DNASU; 13591; -.
DR   Ensembl; ENSMUST00000081265; ENSMUSP00000080020; ENSMUSG00000057098. [Q07802-1]
DR   GeneID; 13591; -.
DR   KEGG; mmu:13591; -.
DR   UCSC; uc007ink.2; mouse. [Q07802-1]
DR   CTD; 1879; -.
DR   MGI; MGI:95275; Ebf1.
DR   VEuPathDB; HostDB:ENSMUSG00000057098; -.
DR   eggNOG; KOG3836; Eukaryota.
DR   GeneTree; ENSGT00950000182859; -.
DR   InParanoid; Q07802; -.
DR   OMA; DDLFLHR; -.
DR   TreeFam; TF313391; -.
DR   BioGRID-ORCS; 13591; 6 hits in 74 CRISPR screens.
DR   ChiTaRS; Ebf1; mouse.
DR   EvolutionaryTrace; Q07802; -.
DR   PRO; PR:Q07802; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; Q07802; protein.
DR   Bgee; ENSMUSG00000057098; Expressed in external carotid artery and 260 other tissues.
DR   ExpressionAtlas; Q07802; baseline and differential.
DR   Genevisible; Q07802; MM.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0070742; F:C2H2 zinc finger domain binding; ISO:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:MGI.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:MGI.
DR   CDD; cd11606; COE_DBD; 1.
DR   CDD; cd01175; IPT_COE; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 2.60.40.3180; -; 1.
DR   InterPro; IPR032200; COE_DBD.
DR   InterPro; IPR038173; COE_DBD_sf.
DR   InterPro; IPR032201; COE_HLH.
DR   InterPro; IPR038006; COE_IPT.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR003523; Transcription_factor_COE.
DR   InterPro; IPR018350; Transcription_factor_COE_CS.
DR   PANTHER; PTHR10747; PTHR10747; 1.
DR   Pfam; PF16422; COE1_DBD; 1.
DR   Pfam; PF16423; COE1_HLH; 1.
DR   Pfam; PF01833; TIG; 1.
DR   SMART; SM00429; IPT; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS01345; COE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Developmental protein; Direct protein sequencing; DNA-binding;
KW   Isopeptide bond; Metal-binding; Nucleus; Reference proteome; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..591
FT                   /note="Transcription factor COE1"
FT                   /id="PRO_0000107826"
FT   DOMAIN          262..345
FT                   /note="IPT/TIG"
FT   ZN_FING         151..170
FT                   /note="C5-type"
FT                   /evidence="ECO:0000269|PubMed:20876732,
FT                   ECO:0007744|PDB:3MLN, ECO:0007744|PDB:3MLO,
FT                   ECO:0007744|PDB:3MLP"
FT   REGION          1..21
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          63..66
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000269|PubMed:20876732,
FT                   ECO:0007744|PDB:3MLN, ECO:0007744|PDB:3MLO,
FT                   ECO:0007744|PDB:3MLP"
FT   REGION          197..204
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000269|PubMed:20876732,
FT                   ECO:0007744|PDB:3MLN, ECO:0007744|PDB:3MLO,
FT                   ECO:0007744|PDB:3MLP"
FT   REGION          236..239
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000269|PubMed:20876732,
FT                   ECO:0007744|PDB:3MLN, ECO:0007744|PDB:3MLO,
FT                   ECO:0007744|PDB:3MLP"
FT   REGION          457..480
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..18
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   SITE            163
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000269|PubMed:20876732,
FT                   ECO:0007744|PDB:3MLN, ECO:0007744|PDB:3MLO,
FT                   ECO:0007744|PDB:3MLP"
FT   SITE            172
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000269|PubMed:20876732,
FT                   ECO:0007744|PDB:3MLN, ECO:0007744|PDB:3MLO,
FT                   ECO:0007744|PDB:3MLP"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UH73"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UH73"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9UH73"
FT   VAR_SEQ         252..259
FT                   /note="Missing (in isoform Short)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_001112"
FT   MUTAGEN         63
FT                   /note="R->A: Strongly reduced interaction with DNA."
FT                   /evidence="ECO:0000269|PubMed:20876732"
FT   MUTAGEN         66
FT                   /note="N->A: Reduced interaction with DNA."
FT                   /evidence="ECO:0000269|PubMed:20876732"
FT   MUTAGEN         163
FT                   /note="R->A: Strongly reduced interaction with DNA."
FT                   /evidence="ECO:0000269|PubMed:20876732"
FT   MUTAGEN         203
FT                   /note="G->E: Strongly reduced interaction with DNA."
FT                   /evidence="ECO:0000269|PubMed:20876732"
FT   MUTAGEN         235
FT                   /note="H->A: Strongly reduced interaction with DNA."
FT                   /evidence="ECO:0000269|PubMed:20876732"
FT   CONFLICT        87
FT                   /note="T -> F (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        89
FT                   /note="F -> L (in Ref. 1; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          36..38
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   HELIX           39..44
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          48..56
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          60..63
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          66..76
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          83..93
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   HELIX           95..97
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   HELIX           99..101
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          108..115
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          121..132
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   TURN            133..135
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   HELIX           148..150
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          152..155
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   HELIX           157..160
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   HELIX           162..165
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   HELIX           171..175
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          181..183
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   TURN            184..186
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          187..194
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          201..204
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          211..219
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          221..228
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   STRAND          232..235
FT                   /evidence="ECO:0007829|PDB:3MLN"
FT   TURN            238..241
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   TURN            249..251
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   STRAND          263..266
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   STRAND          271..273
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   STRAND          279..285
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   STRAND          292..295
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   STRAND          298..300
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   STRAND          302..306
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   STRAND          309..313
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   STRAND          321..329
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   STRAND          332..335
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   STRAND          340..345
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   TURN            351..361
FT                   /evidence="ECO:0007829|PDB:3MLP"
FT   HELIX           375..389
FT                   /evidence="ECO:0007829|PDB:3MLP"
SQ   SEQUENCE   591 AA;  64464 MW;  E47797B6FC1E5071 CRC64;
     MFGIQESIQR SGSSMKEEPL GSGMNAVRTW MQGAGVLDAN TAAQSGVGLA RAHFEKQPPS
     NLRKSNFFHF VLALYDRQGQ PVEIERTAFV GFVEKEKEAN SEKTNNGIHY RLQLLYSNGI
     RTEQDFYVRL IDSMTKQAIV YEGQDKNPEM CRVLLTHEIM CSRCCDKKSC GNRNETPSDP
     VIIDRFFLKF FLKCNQNCLK NAGNPRDMRR FQVVVSTTVN VDGHVLAVSD NMFVHNNSKH
     GRRARRLDPS EGTPSYLEHA TPCIKAISPS EGWTTGGATV IIIGDNFFDG LQVIFGTMLV
     WSELITPHAI RVQTPPRHIP GVVEVTLSYK SKQFCKGTPG RFIYTALNEP TIDYGFQRLQ
     KVIPRHPGDP ERLPKEVILK RAADLVEALY GMPHNNQEII LKRAADIAEA LYSVPRNHNQ
     LPALANTSVH AGMMGVNSFS GQLAVNVSEA SQATNQGFTR NSSSVSPHGY VPSTTPQQTN
     YNSVTTSMNG YGSAAMSNLG GSPTFLNGSA ANSPYAIVPS SPTMASSTSL PSNCSSSSGI
     FSFSPANMVS AVKQKSAFAP VVRPQTSPPP TCTSTNGNSL QAISGMIVPP M
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024